Artificial Intelligence

Abridge Secures $12.5M to Power AI-Powered Medical Conversations

What You Should Know: – Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures. – The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner …

Abridge Secures $12.5M to Power AI-Powered Medical Conversations Read More »

VLRC Brings AI-Driven Diabetic Eye Screening to Rural & Indigenous Communities

What You Should Know: – Vision Loss Rehabilitation Canada (VLRC) and Eyenuk, Inc. launches of VLRC’s Eye Health Screening Initiative to screen rural, remote and Indigenous populations in Northern and Eastern Ontario for diabetic retinopathy (DR), the leading cause of blindness among working-age adults, using Eyenuk’s autonomous AI technology. – VLRC is training local community …

VLRC Brings AI-Driven Diabetic Eye Screening to Rural & Indigenous Communities Read More »

Evidence Partners Raises $20M for Automated, Evidence-Based Research

What You Should Know: – Evidence Partners has announced a growth financing round, their first ever, for $20M, led by Thomvest Ventures.  – With their new AI product DistillerSR, Evidence Partners are changing the way Literature Reviews are conducted, making them efficient, accurate, and less labour-intensive. AI-Driven Literature Review Software DistillerSR is a web-based platform …

Evidence Partners Raises $20M for Automated, Evidence-Based Research Read More »

FDA okays ProstatID software for detecting prostate cancer in MRI

Magnetic resonance imaging (MRI) technology specialist Bot Image has won FDA approval for its artificial intelligence-powered software ProstatID, used for the detection and diagnosis of prostate cancer. The software is combined with traditional MRI scanning to improve the “accuracy and speed” of prostate cancer diagnosis by improving the diagnostic resolution of images, according to the …

FDA okays ProstatID software for detecting prostate cancer in MRI Read More »

Digital Front Doors Create Personalized Patient Experience

Aan Chauhan, Chief Technology Officer, Mindtree Heightened patient expectations are changing the way healthcare services are delivered, from the way patients receive care to the way they pay for services and manage their conditions. A need for greater patient-centricity is changing the way payers, providers, and healthcare services organizations do business. The digital front door …

Digital Front Doors Create Personalized Patient Experience Read More »

What is the Potential for Digital Twins in Healthcare?

David Talby, CTO, John Snow Labs Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, and use simulation, machine learning and reasoning to help decision-making (IBM). In most cases, this helps data scientists understand how products are operating in production environments and anticipate how they …

What is the Potential for Digital Twins in Healthcare? Read More »

3 reasons you should use NLP to make sense of SDOH

Obtaining an understanding of how specific SDOH factors affect individuals is extremely difficult because SDOH data is not methodically collected by clinicians. Natural Language Processing (NLP), a key discipline of AI that uses computers to understand the written word, can overcome this challenge,

Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists

What You Should Know: – Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology. – Together, Tribun …

Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists Read More »

A Hybrid, Technology-Driven Approach to Overcome Coding and RCM Staff Shortages

Cheryl Cruver, Chief Revenue Officer, AGS Health Exacerbated by pandemic-induced burnout, resignations, and even terminations1, chronic coding and revenue cycle management (RCM) staffing shortages have healthcare organizations struggling to find ways to keep revenue flowing despite a lack of qualified professionals to handle critical processes. It is a situation that has been brewing for years, …

A Hybrid, Technology-Driven Approach to Overcome Coding and RCM Staff Shortages Read More »

TidalHealth to Deploy AI Co-Pilot to Combat Clinician Burnout

What You Should Know: – TidalHealth, a health system dedicated to community health and patient-centric care, today announced a new partnership with Regard, a company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, and hip. – Through the implementation of Regard’s software, physicians within the TidalHealth network are able to …

TidalHealth to Deploy AI Co-Pilot to Combat Clinician Burnout Read More »

Oncoustics raises $5.5m for ‘virtual biopsy’ AI platform

Digital health startup Oncoustics has raised $5.5 million in seed funding to develop an artificial intelligence-powered technology that will be used to spot and diagnose liver diseases from ultrasound images. The new company – based in Toronto and San Francisco – will use the new funding to accelerate the development of its lead software-as-a-medical device …

Oncoustics raises $5.5m for ‘virtual biopsy’ AI platform Read More »

RapidAI Awarded FDA Clearance for AI-Powered CT Scans to Identify Intracerebral Hemorrhage

What You Should Know: – RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA clearance for Rapid Hyperdensity, the newest addition to the RapidAI platform. – The tool empowers physicians to quickly assess the severity of injury in patients with acute neuro conditions …

RapidAI Awarded FDA Clearance for AI-Powered CT Scans to Identify Intracerebral Hemorrhage Read More »

The Benefits of Supporting Medical Information Teams with AI Agents

Richard Marcil, Chief Customer Officer at ConversationHEALTH Simon Johns, Director of Medical Information and Marketed Product Safety at IQVIA Life science organizations field a wide range of requests for medical information from the healthcare providers and patients they serve. Addressing these inquiries is important from numerous perspectives, from customer support and pharmacovigilance to post-market surveillance, …

The Benefits of Supporting Medical Information Teams with AI Agents Read More »

New Study Links One Drop’s AI-Powered Blood Glucose Forecasts to Better Engagement and Diabetes Outcomes

What You Should Know: – One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions,  announced outcomes from a retrospective cohort study published in the Journal of Medical Internet Research (JMIR) on the effects of its novel AI-powered blood glucose (BG) forecasting feature. – In the present study, cohort …

New Study Links One Drop’s AI-Powered Blood Glucose Forecasts to Better Engagement and Diabetes Outcomes Read More »

Caption Health Receives CE Mark for AI Ultrasound Tech

What You Should Know: – Caption Health, the leader in using artificial intelligence (AI) and services to improve heart ultrasound access, today announced that it has received a CE Mark for its Caption AI™ technology platform. – This certification represents the first step in making Caption Health’s industry-leading technology platform available outside the US, and …

Caption Health Receives CE Mark for AI Ultrasound Tech Read More »

Executive Roundtable: Can Innovation Alleviate Clinician Burnout?

The U.S. Surgeon General’s recent advisory about clinician burnout cited numerous societal, cultural, structural, and organizational causes—including excessive workloads, administrative burden, and lack of organizational support. The potential fallout of this trajectory is alarming: The advisory cites the Association of American Medical Colleges’ estimate on clinician demand outpacing supply, with an anticipated shortage of between 54,100 and 139,000 physicians predicted by 2033. No one would argue that …

Executive Roundtable: Can Innovation Alleviate Clinician Burnout? Read More »

Liberation from memorization: How technology can improve clinical decision-making

Physicians and advanced practice providers are expected to commit to memory nearly limitless data. With time and properly developed and vetted software, we could move away from a memory-based system where we create general statements for people to memorize, to a new world where we augment our thinking based on population datasets.

Novartis turns to algorithms developer Anumana to apply AI to cardio conditions

Novartis is partnering with algorithms startup Anumana to develop a new artificial intelligence-based solution for cardiovascular diseases. The goal is to find ways to detect heart conditions years before symptoms develop in order to enable earlier intervention.

Wysa Secures $20M for AI-Powered Mental Health Chatbot

What You Should Know:  – Wysa, a Boston, MA-based AI digital platform for mental health, today announces it has secured $20M in financing led by HealthQuad, who along with British International Investment (BII), the UK’s development finance institution, joins earlier investors W Health Ventures, Kae Capital, Google Assistant Investments, and pi Ventures amongst others. – …

Wysa Secures $20M for AI-Powered Mental Health Chatbot Read More »

Northwell Health Selects Google Cloud to Accelerate Digital Transformation

What You Should Know: – Northwell Health, New York State’s largest health care provider and private employer, and Google Cloud today announced a collaboration to improve patient care, clinician experiences, and to help the health and hospital network operate more efficiently.  – Privacy and security will be of the utmost importance in all aspects of this digital …

Northwell Health Selects Google Cloud to Accelerate Digital Transformation Read More »

EU-based I3LUNG project applying AI to lung cancer care gets underway

An EU-funded project that aims to encourage the implementation of artificial intelligence-based personalised care for lung cancer patients – dubbed I3LUNG – has formally launched. The initiative has been awarded €10 million in backing from the Horizon Europe fund over the next five years, and brings together 16 partners from Europe, the US, and Israel …

EU-based I3LUNG project applying AI to lung cancer care gets underway Read More »

$3.7 Trillion Reasons to Centralize Chronic Disease Management

Ty Vachon M.D., Cofounder at Oatmeal Health 59% of all Americans (194 million) suffer from at least one chronic disease, and almost one in three adults has three or more chronic conditions.  Unfortunately, the problem will only get worse with time.  On the business front of chronic disease management, health care systems are already struggling with …

$3.7 Trillion Reasons to Centralize Chronic Disease Management Read More »

Geisinger Taps Cohere Health to Streamline Prior Authorizations

What You Should Know: – Today Geisinger Health Plan (GHP) and Cohere Health, a provider of utilization management (UM) technology, announced they are joining forces to streamline the prior authorization process for providers. – Cohere’s collaborative UM platform will help GHP support value-based care delivery, reduce administrative costs, and lead the nation in aligning quality improvement initiatives across all its lines of …

Geisinger Taps Cohere Health to Streamline Prior Authorizations Read More »

FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics

What You Should Know: – Today, Eko, a digital health company advancing heart and lung disease detection, has announced the FDA has issued clearance for its Eko Murmur Analysis Software (EMAS), the first and only machine learning algorithm to screen for valvular heart disease (VHD). – The next generation of Eko’s murmur detection capabilities grants Eko the first and only smart stethoscope on the market that …

FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics Read More »

GE Healthcare Launches First 5G Innovation Lab for Remote Care

What You Should Know:  – GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator, inaugurated its 5G Innovation Lab in Bengaluru, India, the first for GE Healthcare across the globe. – With the advantage of massive bandwidth, high data speeds, low latency, and highly reliable connectivity, 5G has the potential to disrupt …

GE Healthcare Launches First 5G Innovation Lab for Remote Care Read More »

AI-powered smartphone app monitors IBS using poo images

Researchers in the US have developed an app that uses a smartphone camera and artificial intelligence algorithms to assess images of patients’ poo for signs of disorders like irritable bowel syndrome (IBS). The tool is intended as an alternative to patients’ self-reporting stool form and frequency using the seven-point Bristol Stool Scale (BSS), which ranks …

AI-powered smartphone app monitors IBS using poo images Read More »

Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. That’s the conclusion of a GlobalData report, which notes that AI is being used to enhance computer-aided drug design (CADD) in a bid to …

Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ Read More »

How AI Can Accurately Detect Diabetes Through Retinal Images

Recent advancements in AI have demonstrated that AI can accurately detect diabetes through the analysis of retinal images that retina experts would consider healthy. To better understand this achievement, it is worth taking a step back to understand the context and magnitude of the achievement.  Diabetes is a chronic health condition that affects the body’s …

How AI Can Accurately Detect Diabetes Through Retinal Images Read More »

Regard Raises $15.3M for AI Co-Pilot to Diagnose Medical Conditions

What You Should Know: – Regard (formerly known as HealthTensor), a L.A.-based software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, announced its $15.3 million in Series A funding led by Calibrate Ventures and Foundry Group, with participation from additional investors. – The funding will be used to help …

Regard Raises $15.3M for AI Co-Pilot to Diagnose Medical Conditions Read More »

Merck launches accelerator programme for AI startups

Merck & Co is looking for startup companies applying artificial intelligence, machine-learning and other digital approaches to drug discovery and development for a new accelerator programme. The big pharma – known as MSD outside North America – is initially offering support to 12 companies though the newly-formed Merck Digital Sciences Studio (MDSS) and is now …

Merck launches accelerator programme for AI startups Read More »

Merck Digital Sciences Studio Launches to Support Biomedical Startups

What You Should Know: – Merck, today announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. – MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery …

Merck Digital Sciences Studio Launches to Support Biomedical Startups Read More »

Bayer launches digital AI platform for radiology specialists

Bayer has stepped up the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI and CT imaging. The cloud-hosted platform – called Calantic Digital Solutions – has tools to help radiologists detect and quantify disease lesions in medical images and select patients for treatment in order of priority, …

Bayer launches digital AI platform for radiology specialists Read More »

Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions

Barry Mulchrone, Senior Director& Head of Pharmacovigilance Oversight and Analytics, IQVIA Annette Williams, VP & Global Head, Lifecycle Safety, IQVIA Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) …

Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions Read More »

Metaverse in healthcare

Dr. Mona Flores, Global Head of Medical AI at Nvidia, will deliver the keynote talk kicking off the MedCity INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented in collaboration with Health Wildcatters. Register today.

Olive Launches Autonomous Revenue Cycle (ARC) Suite

What You Should Know: – Olive, the automation company creating the Internet of Healthcare, today launched its Autonomous Revenue Cycle (ARC), the company’s flagship Revenue Cycle Management (RCM) suite of solutions. – Olive’s ARC is designed to handle tedious, time-consuming administrative tasks in the revenue cycle, allowing healthcare organizations to get paid quicker while reducing the …

Olive Launches Autonomous Revenue Cycle (ARC) Suite Read More »

When It Comes to Digital Health, Experience Is Everything

Aniket Singh Rajput, Founder and CEO of Neuroglee Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Whether it is streaming video telehealth appointments with a provider, a …

When It Comes to Digital Health, Experience Is Everything Read More »

Fujifilm acquires AI tech to improve fertility treatment

Fujifilm’s Irvine Scientific unit has licensed rights to an artificial intelligence-powered technology developed to improve the success rate of in vitro fertilisation (IVF) techniques. The cell culture specialist, a player in assisted reproductive technologies (ART), has licensed the platform from Brigham and Women’s Hospital and Massachusetts General Hospital, where it was developed. During IVF, egg …

Fujifilm acquires AI tech to improve fertility treatment Read More »

Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion

Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to …

Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion Read More »

Lessons from the Pandemic and the Smart Facilities of Tomorrow

Charlie Meyer, Senior Vice President of Sales, QLess  As much as we all wish it were otherwise, the COVID-19 pandemic continues to claim lives and upset stability around the world. If this worldwide disaster has a narrow silver lining, it is the many lessons it has to teach us moving forward. These lessons cover every …

Lessons from the Pandemic and the Smart Facilities of Tomorrow Read More »

How IoT Data Integration Helps Deliver Improved At-Home Healthcare in 2022

Patricia (Pat) Black, Director of Technical Solutions at Cardinal Peak When it comes to your health and treatment, hospitals leverage a variety of sensors and instruments to collect the necessary information to monitor and diagnose your health status. With essential health data integrated into one platform, healthcare professionals are able to quickly and easily monitor …

How IoT Data Integration Helps Deliver Improved At-Home Healthcare in 2022 Read More »

SAE Media Group’s 2nd Annual Biosensors for Medical Wearables Conference

SAE Media Group’s 2nd Annual Biosensors for Medical Wearables *In collaboration with Medical Design Briefs* 24th – 25th October 2022 | Boston, MA, USA Sponsored by: Raumedic http://www.biosensors-medical-wear.com/PharmaPhorum Advances in development and therapeutic applications of on-body sensors SAE Media Group is proud to present the Biosensors for Medical Wearables Conference, taking place on the 24th …

SAE Media Group’s 2nd Annual Biosensors for Medical Wearables Conference Read More »

AI specialist Charm Therapeutics launches with $50m Series A

The UK’s fertile environment for biotechs specialising in artificial intelligence has generated a new player – Charm Therapeutics – which came out of stealth mode this morning with a $50 million first-round financing. The London-based startup has been founded by David Baker, head of the Institute of Protein Design at the University of Washington in …

AI specialist Charm Therapeutics launches with $50m Series A Read More »

Owkin bags $180m BMS alliance for cardiovascular clinical trials

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is paying $80 million upfront to tap into its expertise. The deal is split between a Series B financing led by BMS and upfront fees, taking the total raised by the Paris, France-based start-up to $300 million, and …

Owkin bags $180m BMS alliance for cardiovascular clinical trials Read More »

The state of AI in drug discovery

The MedCity INVEST PhrmaTech virtual conference, scheduled for Tuesday, July 26, offers free registration and a compelling day of conversations exploring the convergence of the health tech and biopharma sectors.

Sanofi Launches Its First Digital Health Accelerator to Address Unmet Patient Needs

What You Should Know: – Sanofi launched its first Digital Accelerator to better leverage data and artificial intelligence to develop solutions that address unmet patient needs. – The Digital Accelerator team is developing an integrated platform and data solution to enhance awareness of atopic dermatitis and available treatment options amongst patients and HCPs. Digital Accelerator Focus The Digital Accelerator is the next …

Sanofi Launches Its First Digital Health Accelerator to Address Unmet Patient Needs Read More »

AI for Behavioral Health Gets Boost With Ontrak-Eleos Partnership

What You Should Know: – Eleos Health, a behavioral health tech company and Ontrak Health (NASDAQ: OTRK), a healthcare company are teaming up to integrate their respective  AI platforms to support behavioral health care for Ontrak’s members.– Ontrak specializes in serving the most vulnerable members of the behavioral health population who would otherwise fall through …

AI for Behavioral Health Gets Boost With Ontrak-Eleos Partnership Read More »

AI specialist Insilico raises $60m as more projects head to clinic

Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more drugs towards the clinical testing stage. The Hong Kong-based startup – one of an emerging crop of companies which are using artificial intelligence platforms to discover and design new therapeutic compounds – took its first drug into …

AI specialist Insilico raises $60m as more projects head to clinic Read More »

Why Health Plans Must Have Next-Gen CAPS Technology for Digital Transformation

Sagnik Bhattacharya Chief Operating & Product Officer HealthEdge Core Administrative Processing Systems (CAPS) operate as the brains behind a health plan’s business. These systems are critical to the smooth functioning of a health plan. Today, many payers run on decades-old CAPS systems built on legacy technologies. This can be a serious drawback.  Legacy systems may …

Why Health Plans Must Have Next-Gen CAPS Technology for Digital Transformation Read More »

4 Patient Flow Challenges Contributing to Provider Burnout

Ben Sawyer, VP of Market Development at ABOUT There has been frequent reporting about the problem of provider workforce shortages within hospitals and health systems and the related burnout experienced when working in high-stress situations during the COVID-19 pandemic. There are pre-existing and contributing patient flow challenges that have been exacerbated by the pandemic, which …

4 Patient Flow Challenges Contributing to Provider Burnout Read More »

Lightbeam Health Acquires Jvion AI and SDOH Solutions – M&A

What You Should Know: – Lightbeam Health Solutions, Inc., a provider of population health management solutions and services has entered into an asset purchase agreement to acquire the operating assets related to Jvion, Inc., including Jvion’s market-leading AI-enabled prescriptive analytics and social determinants of health (SDoH) solutions.  -The strategic partnership combines Lightbeam’s health analytics and outcomes …

Lightbeam Health Acquires Jvion AI and SDOH Solutions – M&A Read More »

LeanTaas CEO: EHRs are not built to handle capacity optimization

One of the biggest sources of patient dissatisfaction is waiting. LeanTaaS founder and CEO Mohan Giridharadas says hospitals are much better off using SaaS products embedded with sophisticated artificial intelligence to optimize their capacity rather than relying on their EHR capabilities or in-house data analysts if they want to see measurable results.

Geisinger & Tempus Create AI Model to Identify Structural Heart Disease

What You Should Know: – Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the …

Geisinger & Tempus Create AI Model to Identify Structural Heart Disease Read More »

Geisinger Selects AWS as Strategic Cloud Provider to Migrate Over 400 Apps to AWS

What You Should Know: – Geisinger has chosen Amazon Web Services (AWS) as its strategic cloud provider and will transition its entire digital portfolio of more than 400 applications and numerous workflows to AWS. – The project will be one of the largest electronic health record (EHR) cloud migrations to AWS to date, expected to …

Geisinger Selects AWS as Strategic Cloud Provider to Migrate Over 400 Apps to AWS Read More »

Olive Partners with Magenta to Revolutionize Risk Adjustment Process

What You Should Know: – Olive, the automation company creating the Internet of Healthcare, today announced its partnership with Magenta Care Continuum, a HIPAA-compliant health records vault that includes care gap analytics. – Through the Olive Library, payers and providers can access Magenta’s solutions to help close care gaps, improve billing and claims occurrence and ensure compliance and …

Olive Partners with Magenta to Revolutionize Risk Adjustment Process Read More »

Pfizer and Sidekick Health Launches Digital Therapeutics Solution for Eczema

What You Should Know: – Sidekick Health today announces the launch of an integrated digital therapeutics solution for improving the outcomes of patients with Atopic Dermatitis (AD) in conjunction with Pfizer Inc., one of the world’s premier innovative biopharmaceutical companies. – Sidekick and Pfizer will be rolling out their integrated digital therapeutics offering, launching first …

Pfizer and Sidekick Health Launches Digital Therapeutics Solution for Eczema Read More »

How AI is transforming remote cardiac care for patients

The average heart beats about 1.5 million times over two weeks, and physicians might have to identify a six-second time period, which can determine a clinical outcome. Finding what’s clinically meaningful can be a needle in the haystack type of problem, and AI ensures higher accuracy at scale.

INVEST Pitch Perfect winner: Modality.ai makes Tina the Alexa of clinical trials

Modality.ai has developed a conversational AI system that replaces in-person interviews that are part of neurological assessments for a range of disorders. The startup was judged co-winner in the pharmatech category during the recent MedCity INVEST conference in Chicago.

Patient Flow Challenges Contributing to Provider Burnout

Ben Sawyer, VP of Market Development at ABOUT Healthcare, Inc There has been frequent reporting about the problem of provider workforce shortages within hospitals and health systems and the related burnout experienced when working in high-stress situations during the Covid-19 pandemic. There are pre-existing and contributing patient flow challenges that have been exacerbated by the …

Patient Flow Challenges Contributing to Provider Burnout Read More »

Clover Therapeutics turns a new leaf as Character Bio to pursue dry AMD & more

Dry age-related macular degeneration currently has no FDA-approved treatments but the research of Clover Therapeutics has yielded two candidates. The biotech startup has made progress in the past two years under CEO Cheng Zhang and it’s now revealing more details about its approach, a new corporate identity, and a Series A financing that puts it …

Clover Therapeutics turns a new leaf as Character Bio to pursue dry AMD & more Read More »

Overjet expands its AI platform to help dentists detect cavities along with gum disease

The Boston-based company announced Monday that it had received 510(k) clearance from the FDA for its Caries Assist, software that uses AI to aid dentists in detecting cavities. In May last year, Overjet received FDA clearance for AI-powered technology used in the diagnosis and treatment of gum disease.

Could AI and an Apple Watch ECG improve the prognosis for heart failure?

Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even when no symptoms are present.

The Academy and Nuance Partner to Launch The AI Collaborative

What You Should Know: – The Health Management Academy (The Academy) has partnered with Nuance, a Microsoft company, to launch The AI Collaborative, which brings together senior leaders from the nation’s Leading Health Systems (LHS) who are deploying these technologies in the clinical and operational settings, as well as planning for future use-cases. – The …

The Academy and Nuance Partner to Launch The AI Collaborative Read More »

Patient Engagement: 3 Lessons Learned from Consumer & Service Industries

Alison Budor, Consultant, Freed Associates If there’s been a constant in healthcare the past two years, it’s been in the rapidity of change, largely in response to the Covid-19 pandemic. Suddenly, healthcare needed to adopt new work models and technologies to provide proper patient care. No wonder healthcare ranked atop all other industries in “new …

Patient Engagement: 3 Lessons Learned from Consumer & Service Industries Read More »

OncoHost Raises $35M for AI-Powered Precision Oncology Platform

What You Should Know: – OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israeli financial firm Leumi Partners, Israel’s largest pension fund Menora Mivtachim, OurCrowd and other existing investors. – The funding will …

OncoHost Raises $35M for AI-Powered Precision Oncology Platform Read More »

Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M

Aspen Neurosciences is developing a cell therapy that uses a patient’s own stem cells to develop a personalized treatment for Parkinson’s disease. The approach is slightly different than that of Bayer, whose experimental Parkinson’s cell therapy is made from stem cells sourced from healthy donors.

How is AI moving the needle in the pharmaceutical industry?

Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.

Cerner & AKASA Partner on AI-Powered Revenue Cycle Automation

What You Should Know: – Health IT leader Cerner and AI developer for healthcare operations AKASA announce a partnership to scale automation within the revenue cycle at hospitals and health systems using AI and machine learning. – The collaboration offers Cerner customers access to AKASA’s AI-based Unified Automation® platform which is purpose-built for healthcare. Growing …

Cerner & AKASA Partner on AI-Powered Revenue Cycle Automation Read More »

SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices Conference

SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices Conference 10 – 11 October 2022 | London, UK http://www.wearable-injectors.co.uk/PharmaPhorum The Latest Innovations In Digital Health And On-Body Drug Delivery For The Pharmaceutical Industry SAE Media Group’s 3rd annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging …

SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices Conference Read More »

Axuall’s CEO Talks Why Health Administrators Should Adopt Robotic Process Automation

Charlie Lougheed, CEO & Founder, Axuall Axuall’s CEO & Founder, Charlie Lougheed shares why health administration teams should embrace the power of robotic process automation (RPA). Built with leading healthcare systems, Axuall is a workforce intelligence company powered by a national real-time practitioner data network. The technology enables healthcare systems, staffing firms, telehealth, and health …

Axuall’s CEO Talks Why Health Administrators Should Adopt Robotic Process Automation Read More »

Element5 Secures $30M to Expand Automation for Post-Acute Care

What You Should Know: – Element5, the world’s first Automation-as-a-Service solution purpose-built for post-acute care, today announced that it has raised $30 million in a Series B funding round led by Insight Partners.  With the closing of the Series B funding round, Element5 has raised $48.5M in total capital to date.  – This investment will …

Element5 Secures $30M to Expand Automation for Post-Acute Care Read More »

Oracle co-founder Larry Ellison leads $21.5m round for Imagene AI

Israeli cancer diagnosis startup Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform based digitised imaging of biopsy samples. The Series A – led by Oracle co-founder Larry Ellison and fellow investors Dr David Ahus and Zebra Medical Vision founder Eyal Gura – includes $3 million in seed funding from …

Oracle co-founder Larry Ellison leads $21.5m round for Imagene AI Read More »

Hello Heart Raises $70M to Expand Heart Health Solutions

What You Should Know: – Hello Heart, the only digital therapeutics company focused exclusively on heart disease, announced a $70M Series D funding round led by Stripes to support its rapid growth in the employer market  – The funding round will specifically support the increase in employer market demand for Hello Heart’s technology as a …

Hello Heart Raises $70M to Expand Heart Health Solutions Read More »

3 Keys to Eliminating Data Breakdowns in Life Sciences

Sudish Mogul, Chief Technology Officer of Healthcare Triangle Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data …

3 Keys to Eliminating Data Breakdowns in Life Sciences Read More »

Former OptumRx CEO Launches Waltz Health with $33M to Lower Drug Costs

What You Should Know: – Mark Thierer — the former CEO of OptumRx who took that role after selling Catamaran to UnitedHealth Group for $13B, today announced the launch of Waltz Health with $35.4M led by GV (Google Ventures) including participation from Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, and Twine Ventures. Other funding came from a prestigious list of seasoned …

Former OptumRx CEO Launches Waltz Health with $33M to Lower Drug Costs Read More »

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%

What You Should Know: – DiA Imaging Analysis Ltd, a global provider of AI-powered ultrasound analysis software, has teamed up with Intel to streamline artificial intelligence (AI) solutions used by echocardiography (Echo) labs. – DiA’s AI-based software, LVivo Seamless™, automatically analyzes cardiac ultrasound images using the Intel® Distribution of OpenVINO™ toolkit, to optimize processing time …

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40% Read More »

Former OptumRx CEO launches startup Waltz Health with $35M, promising to lower drug costs

Pharmacy benefit managers have been widely criticized for opaque drug pricing practices. But Waltz Health, which was co-founded by former PBM executive Mark Thierer, aims to use insider knowledge and tech solutions to lower drug costs.

Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials

The Series D round of funding makes Biofourmis a unicorn valued at $1.3 billion. CEO and founder Kuldeep Singh Rajput said that the new capital will be used to expand his company’s remote-monitoring technologies and continue development of digital therapeutics, both as companions to traditional drugs and as monotherapies.

3 Steps to Approach & Tackle Digital Transformation in Healthcare

Michael Norring, President and CEO of GCSIT Artificial intelligence (AI) is predicted to save the US healthcare economy $150 billion by 2026. Replacing legacy systems and changing standard operating procedures, hospitals are moving to capitalize on technology and the ways it can change a historically hesitant to change sector. The big question is how fast …

3 Steps to Approach & Tackle Digital Transformation in Healthcare Read More »

As AI’s role in combating clinician burnout grows, Suki expands its voice-enabled capabilities

The voice solution Suki Assistant uses machine learning and natural language processing to accurately understand and document information and respond to physician commands, according to the company.

How Automation Can Help with Healthcare’s “Messy” Data Problem

Dr. Bob Lindner, Co-Founder & Chief Technology Officer of veda Efficient data processing and data sharing are essential functions across healthcare—from patient care, clinical research, and health services planning to billing and government reporting for funding and research. But most of the data that the industry is processing is human-generated, meaning it’s messy and riddled …

How Automation Can Help with Healthcare’s “Messy” Data Problem Read More »

Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions

What You Should Know: – Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care. – Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for …

Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions Read More »

Using NLP Technology To Uncover Real-World Patient Insights

It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected technologies and social media have had on the way we experience our world, it’s somehow even …

Using NLP Technology To Uncover Real-World Patient Insights Read More »

KOL Identification & Mapping Driven By Insights

Insights captured from KOL interactions represent a new way to identify and map the KOL landscape in which your brand must thrive. KOL identification and mapping is often driven by quantitative analytics looking at activity across publications, congresses, trials, social channels, and so forth. Although beneficial in many ways, this activity-driven approach by its very …

KOL Identification & Mapping Driven By Insights Read More »

Therapeutic Alliance: Building Relationships With AI Therapy Chatbots

What You Should Know: – Can we build relationships with AI therapy bots as well as we can with other human beings? This research says yes.  – A recent peer-reviewed study in Frontiers of  Wysa, an advanced conversational AI for mental health, shows people develop an emotional bond with its chatbot in much the same …

Therapeutic Alliance: Building Relationships With AI Therapy Chatbots Read More »

Chairman of new Northwell/Aegis accelerator: It will build AI companies much faster

Northwell Health, the largest health system in New York, and startup studio Aegis Ventures announced Tuesday that they had launched the AI company creation platform Ascertain. The partnership brings $100 million in seed-stage funding and permanent long-term growth capital to launch companies at scale.

Increasing access and equity in healthcare through AI

While many healthcare companies have used artificial intelligence for some time now for features like machine learning interpretability required by the healthcare industry for compliance purposes, AI-based healthcare solutions also have the potential to make healthcare more affordable and more accessible, thus helping to improve equity in healthcare.

Planning ahead while looking back: What the pandemic collectively taught us

As artificial intelligence becomes more focused and efficient, and the pharmaceutical and biotech industries consolidate to survive, it’s important to also reflect on what is working in the fight against Covid-19. This will help us to be more prepared for the next global health crisis.

Arterys Receives FDA Clearance for Next-Gen Cardiac MRI App

What You Should Know: – Arterys, the world’s leading vendor-neutral artificial intelligence (AI) platform, has announced several new modules to its already robust Cardio AI clinical application and an additional FDA AI clearance based on deep learning.  – Cardio AI is a comprehensive, cloud-based post-processing solution that leverages AI and deep learning to provide extremely …

Arterys Receives FDA Clearance for Next-Gen Cardiac MRI App Read More »

PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development

What You Should Know: – PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH). – As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better …

PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development Read More »

MedTech: Transforming Healthcare with Medical Imaging AI

Travis Richardson, Chief Strategist at Flywheel Healthcare providers and their patients stand to benefit dramatically from AI technologies, thanks to their ability to leverage data at scale to reveal new insights. But for AI developers to perform the research that will feed the next wave of breakthroughs, they first need the right data and the …

MedTech: Transforming Healthcare with Medical Imaging AI Read More »

Viz.ai Raises $100M for Care Coordination Platform at $1.2B Valuation

What You Should Know: – Viz.ai, a San Francisco-based AI-powered disease detection and care coordination platform raises $1000M in Series D funding led by Tiger Global and Insight Partners. The round also included participation from Scale Ventures, Kleiner Perkins, Threshold, GV (formerly Google Ventures), Sozo Ventures, CRV, and Susa.  – The new funds will be used to support Viz.ai’s significant growth trajectory, …

Viz.ai Raises $100M for Care Coordination Platform at $1.2B Valuation Read More »

Cardiologs’ AI Dramatically Reduces Inconclusive Apple Watch ECGs

What You Should Know: – Cardiologs, a provider of artificial intelligence (AI) cardiology diagnostics, today announced the results of a new clinical study that showed Cardiologs’ deep learning AI dramatically reduces inconclusive results returned by the latest Apple Watch ECG companion app (Apple ECG 2.0) while maintaining performance (sensitivity and specificity).  – The study included …

Cardiologs’ AI Dramatically Reduces Inconclusive Apple Watch ECGs Read More »

Takeda returns to Evozyne’s AI tech, seeking novel proteins for next-gen gene therapies

Evozyne uses artificial intelligence and machine learning to design novel proteins that can be used in gene therapies. The new agreement with Takeda Pharmaceutical covers the development of proteins that can be used in gene therapies for rare diseases.

AI test could predict best cancer therapies for patients

Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patients within two days. The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking …

AI test could predict best cancer therapies for patients Read More »

Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation

Bayer is committing another €1.3 billion to Leaps by Bayer, the company’s investment arm, to support additional investments in companies developing innovative technologies in healthcare and agriculture. In addition to backing companies developing cell and gene therapies, Leaps has also deployed its cash to startups developing artificial intelligence technologies for a range of applications.

Dental AI Startup VideaHealth Nabs $20M to Expand AI-Based Diagnostics

What You Should Know: – VideaHealth, a dental diagnostic AI solution raises $20M in Series A funding led by Spark Capital including existing investors Zetta Venture Partners. Pillar VC also contributed to the round, bringing the company to $26.4M to date. – The company will use the financing to expand its groundbreaking AI-based diagnostics capabilities to over 6000 …

Dental AI Startup VideaHealth Nabs $20M to Expand AI-Based Diagnostics Read More »

Health Care Organizations Must Prioritize Cybersecurity Before Undergoing Digital Transformation

By TRAVIS GOOD The health care industry is rapidly embracing new technologies. Covid-19 changed the way many industries operate, and healthcare is one industry that was particularly affected by the pandemic. Many health care organizations were already undergoing digital transformations, but Covid exponentially sped up those processes. Health care providers and health-tech companies were forced …

Health Care Organizations Must Prioritize Cybersecurity Before Undergoing Digital Transformation Read More »

Researchers Develop AI Method for Personalized Diabetes Treatment

What You Should Know: – Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized care for diabetes patients needing complex drug treatment. – The new AI method can now be used to help determine an optimal drug regimen for a specific patient. Hitachi, University …

Researchers Develop AI Method for Personalized Diabetes Treatment Read More »

Paige launches software to help detect breast cancer that has spread to the lymph nodes

When breast cancer spreads, it commonly invades the lymph nodes—structures that are part of the body’s immune system. Paige’s software is designed to find cancer in the lymph nodes that might otherwise be missed, like tiny collections of cancer cells called micrometastases.

Celsius Therapeutics heats up with $83M and an IBD drug on path to the clinic

Single-cell analysis biotech Celsius Therapeutics has raised $83 million to advance its pipeline of drugs for autoimmune disorders and cancer. The startup’s lead autoimmune program, a TREM1-blocking antibody for inflammatory bowel disease, is expected to begin human testing in early 2023.

Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage

Adam Marko, Director of Life Science Solutions at Panasas The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down. In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing …

Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage Read More »

When Automation Meets Empathy: Intelligent Virtual Assistants for Healthcare

Nate Treloar, COO & Co-Founder at Orbita Advances in conversational artificial intelligence are transforming basic chatbots into intelligent virtual assistants that provide comfort and utility for healthcare consumers and the healthcare organizations that serve them.   Most consumers have their minds made up about automated phone agents, and not too many people like them. Who …

When Automation Meets Empathy: Intelligent Virtual Assistants for Healthcare Read More »

GSK joins LifeMine’s $175M funding as partners revive fungi as a drug discovery frontier

LifeMine Therapeutics, a company that analyzes fungal genomes to find molecules that have potential as new medicines, has raised $175 million in financing. Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target drug discovery alliance.

Sanofi backs precision oncology firm Nucleai in $33m fundraising

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial intelligence and spatial biology to find biomarkers that can predict which patients will respond to cancer treatments. The five-year-old company uses machine vision and learning technology originally developed for military applications to predict …

Sanofi backs precision oncology firm Nucleai in $33m fundraising Read More »

CMR Surgical Launches VR Education Solution for Soft Tissue Robotic Surgery

What You Should Know: – Today, CMR Surgical has announced a VR professional education program for its Versius® Surgical Robotic System.   – The announcement marks CRM Surgical as the first soft-tissue surgical robotics system to offer VR training as part of its surgical team training pathway; giving surgical teams increased flexibility to practice their skills. VR Training for Surgical Robot The VR headset solution was …

CMR Surgical Launches VR Education Solution for Soft Tissue Robotic Surgery Read More »

Tempus Launches Pathology-Driven AI Platform

What You Should Know: – Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. – With access to over 50 petabytes of de-identified …

Tempus Launches Pathology-Driven AI Platform Read More »

Digital pathology companies score partnerships with marquee providers to leverage ML on image analysis

PathAI is partnering with Cleveland Clinic to digitize pathology slides and develop and improve PathAI’s machine-learning algorithms that can drive research as well as improve patient outcomes in a clinical setting. Pramana is launching its digital pathology as a service product and has struck a 5-year commercial agreement with Mayo Clinic to digitize 5 million …

Digital pathology companies score partnerships with marquee providers to leverage ML on image analysis Read More »

Canopy Launches Out of Stealth with $13M for Intelligent Care Platform for Oncology

What You Should Know:  – Today,  Canopy announced it is launching out of stealth with $13 million in funding to work with leading oncology practices all over the country to help deliver high-quality care to cancer patients when they aren’t in the doctor’s office. – Canopy works with leading oncology practices nationwide to drive the …

Canopy Launches Out of Stealth with $13M for Intelligent Care Platform for Oncology Read More »

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage …

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration Read More »

HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions

Mergers & Acquisitions (M&A) Activity OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform OptimizeRx, a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes …

HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions Read More »

Diabetes data put Better Therapeutics’ digital offering on track for FDA filing

Better Therapeutics reported that its digital therapeutic for type 2 diabetes met the main goal of a pivotal study. An FDA submission is expected in the middle of this year, followed by additional clinical trials testing digital therapeutics developed for other cardiometabolic disorders.

House Rx Secures $30M to Optimize the Specialty Pharmacy Experience for Patients and Their Care Teams

What You Should Know: – Today House Rx, a health technology platform that empowers oncology and rheumatology physician practices with medically integrated dispensing, announced they’ve secured $30 million in financing. – Founded by two former Flatiron Health executives, Ogi Kavazovic and Tesh Khullar the company has partnered with four medical practices and 30 prescribers since March 2021. House Rx, a …

House Rx Secures $30M to Optimize the Specialty Pharmacy Experience for Patients and Their Care Teams Read More »

Quickbite Interviews: Lark & Luma Health

I was at the VIVE conference in Miami last week and caught up with a number of CEOs & execs for some quickbite interviews — around 5 mins getting (I hope) to the gist of what they & their companies are up to. I am going to dribble them out this week. First two up …

Quickbite Interviews: Lark & Luma Health Read More »

Exploring the technology trends that will define the future of healthcare

While the healthcare industry’s digital transformation continues pushing forward — accelerated, in part, by growing adoption of telehealth — we’re also seeing the effects of a stronger digital foundation for the future of healthcare.

Creyon Bio gets some green for a new take on AI and genetic meds R&D

Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it’s technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.

To Engage and Activate Patients, CRM Alone Isn’t Enough

Michael Linnert, Founder and CEO of Actium Health We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t just want a patient to engage with a piece of content or information; we want them to take action. The traditional CRM and marketing automation are great tools for the …

To Engage and Activate Patients, CRM Alone Isn’t Enough Read More »

Aetion and Cognito Team Up for Predictive Modeling in Alzheimer’s

What You Should Know: – Aetion, real-world evidence (RWE) tech and analytics provider, and Cognito Therapeutics, a pioneer in neuromodulation therapeutics for neurodegenerative diseases like Alzheimer’s, are partnering to develop an AI-driven predictive model to help payers and providers identify patients with rapidly progressing mild cognitive impairment (MCI) and Alzheimer’s who may benefit from earlier treatment.  Impact of MCI …

Aetion and Cognito Team Up for Predictive Modeling in Alzheimer’s Read More »

BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases

What You Should Know: – BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with global biopharma, UC to build digital care solutions for rare diseases. – BrightInsight will build and bring to market a digital disease management solution to support patients with Myasthenia Gravis (MG), …

BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases Read More »

When Crypto Comes to Health Care

By KIM BELLARD The conflict between Ukraine and Russia has been called many things.  To most of the world, of course, it’s considered an invasion, a war between the two countries.  To Russia, it’s a “peacekeeping” mission.  The description that I can’t get out of my head, though, is one that I believe The Washington …

When Crypto Comes to Health Care Read More »

Boehringer backs AI-powered anti-infective startup ArrePath

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including the Boehringer Ingelheim Venture Fund. The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging …

Boehringer backs AI-powered anti-infective startup ArrePath Read More »

Princeton spinout ArrePath gets $20M to combine AI, imaging in antibiotics R&D

Anti-infective drug discovery startup ArrePath has launched with $20 million in seed funding to advance the development of molecules that use a dual mechanism to kill bacteria. The Princeton University spinout says its approach could overcome the drug resistance bacteria are developing to currently available products.

Improving the diagnosis and treatment of rare diseases with AI-based technology

To reduce time-consuming manual searches and improve their findings, many organizations are turning to artificial intelligence technologies such as natural language processing. Clinical and research institutions are adopting NLP to capture unstructured information from EHRs that helps with diagnosis.

How Support Automation Enhances Clinical Trial Management

David Karandish, CEO of Capacity The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase. Clinical trial teams face a …

How Support Automation Enhances Clinical Trial Management Read More »

How Support Automation Enhances Clinical Trial Management

David Karandish, CEO of Capacity The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase. Clinical trial teams face a …

How Support Automation Enhances Clinical Trial Management Read More »

Flagship’s Vesalius launches with $75M to take AI into realm of common diseases

Artificial intelligence is a powerful tool for rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine learning can also be applied to common diseases, and the startup has launched with $75 million in committed financing.

Mount Sinai Selects Accenture and Microsoft on Five-Year Transformation Journey to Cloud

What You Should Know: – Accenture and Microsoft will assist the Mount Sinai Health System (Mount Sinai) with its transition to the cloud to help enable innovation at a much faster pace. – By modernizing its infrastructure, Mount Sinai will be able to reinvest cost-savings and focus on its healthcare mission. The migration to Microsoft …

Mount Sinai Selects Accenture and Microsoft on Five-Year Transformation Journey to Cloud Read More »

Cedars-Sinai Establishes New Division: Artificial Intelligence in Medicine (AIM)

What You Should Know: – Today, the department of Cedars-Sinai announced it has established a new division to explore how artificial intelligence (AI) can be applied to help solve complex medical problems and enhance clinical care. – The new division, Artificial Intelligence in Medicine, or AIM will be led by Sumeet Chugh, MD, an associate …

Cedars-Sinai Establishes New Division: Artificial Intelligence in Medicine (AIM) Read More »

Sanofi and DarioHealth team up on digital health tools for chronic conditions

Sanofi and digital therapeutics company DarioHealth will work together to promote the tech firm’s offerings for the management of chronic diseases. Under the $30 million, multi-year agreement, the partners will also develop new technology tools.

GHX Acquires Syft, AI-Powered Hospital Supply Chain Platform

What You Should Know: – Today GHX announced its acquisition of Syft, a leading provider of AI-enhanced inventory control and end-to-end supply chain management software and services.  – As a wholly-owned subsidiary of GHX, Syft joins GHX’s value-based care division’s growing portfolio of solutions that help modernize the supply chain. Modernizing Healthcare Supply Chain to …

GHX Acquires Syft, AI-Powered Hospital Supply Chain Platform Read More »

Butterfly Launches System-Wide Ultrasound w/AI-Guided Option

What You Should Know: – Butterfly Network today launched Butterfly Blueprint, a system-wide platform that supports scaled deployment of ultrasound across hospitals and health systems. – Blueprint integrates ultrasound information into health systems’ clinical and administrative systems and workflows. That means clinicians across all disciplines now have a tool that allows them to see and know results sooner to drive better care decisions, efficiency and outcomes. Blueprint …

Butterfly Launches System-Wide Ultrasound w/AI-Guided Option Read More »

Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI

Andrew Pucher, CEO of Dascena, Inc. One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. healthcare workforce,4 resulting in staffing shortages in hospitals. This has impacted the well-being of the remaining healthcare practitioners 5 as well as their patients – many of whom are deferring …

Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI Read More »

The value of a human-centric, AI-powered approach to healthcare

Many healthcare companies are examining ways to incorporate AI to improve safety, efficiency and the overall patient experience. However, as companies continue to prioritize this technology, it’s important to focus on finding the right applications, rather than just using it to replace humans.

Viz.ai Awarded 510(k) Clearance for AI-Powered Cerebral Aneurysm Detection Solution

What You Should Know: – Viz.ai, a San Francisco-based provider of AI-powered intelligent care coordination for stroke, has received FDA 510(k) clearance for Viz ANEURYSM (formerly Viz ANX), the first and only AI-powered cerebral aneurysm detection solution designed to facilitate population screening and enhanced care management. – The new algorithm uses AI to detect suspected cerebral aneurysms, enabling hospital systems to ensure that once detected, patients are captured and …

Viz.ai Awarded 510(k) Clearance for AI-Powered Cerebral Aneurysm Detection Solution Read More »

Definitive Healthcare Acquires Analytical Wizards, Healthcare Analytics Platform

What You Should Know: – This week, Definite Healthcare announced the acquisition of Analytical Wizards, an advanced analytics company revolutionizing analytics in healthcare by combining our AI/ML-powered technology, domain expertise, and high-touch relationship model. Financial details of the acquisition were not disclosed. – Founded in 2015, Analytical Wizards automates complex analytic models using tools that …

Definitive Healthcare Acquires Analytical Wizards, Healthcare Analytics Platform Read More »

Story Health Secures $22.6M for AI-Driven Virtual Specialty Care Platform Across Cardiology

What You Should Know: – Story Health, a health technology and services company that extends specialty care into patient’s homes raises $22.6M in Series A funding co-led by Northpond Ventures and B Capital Group. The round also included participation from new investor LRVHealth and existing investors Define Ventures and General Catalyst, bringing the company’s total …

Story Health Secures $22.6M for AI-Driven Virtual Specialty Care Platform Across Cardiology Read More »

Healthcare Is A Cyber Criminal’s Dream, But It Doesn’t Have To Be This Way

Vidya Murthy, Chief Operating Officer at MedCrypt Healthcare is a cyber criminal’s dream. It presents the intersection of a data treasure trove, weak security posture, limited resources, complicated supply chain, and patient care delivery. When faced with having to pick a priority to optimize for, healthcare will, of course, always pick delivering healthcare. This means …

Healthcare Is A Cyber Criminal’s Dream, But It Doesn’t Have To Be This Way Read More »

Study: AI-enabled coronary CT angiography as good if not better than Echo, other tests to identify heart disease

Findings published in Journal of American College of Cardiology found Cleerly’s AI platform matched or outperformed core lab quantitative coronary angiography (QCA), core lab–interpreted coronary computed tomography angiography (CTA), and invasive fractional flow reserve (FFR) for evaluating the severity of coronary arterial stenosis.

Medtronic, AWS to Provide Underserved Communities with AI-Assisted Colon Cancer Screening

Genius Intelligent Endoscopy Module What You Should Know: – Medtronic and AWS, today announced a partnership to provide underserved communities with artificial intelligence (AI)-assisted colonoscopy technology through AWS’s $40M Health Equity Assistance Program for colon cancer screening. – Amazon Web Services will support the effort to provide Medtronic GI Genius™ intelligent endoscopy modules to facilities …

Medtronic, AWS to Provide Underserved Communities with AI-Assisted Colon Cancer Screening Read More »

Sirona Medical Acquires Nines Radiology AI Division

What You Should Know: – Sirona Medical, a software company with a cloud-native solution for radiologists, has announced its acquisition of Nines Radiology’s AI division. Sirona Medical did not acquire Nines’ teleradiology business, Nines Radiology. The terms of the deal were not disclosed. – This is Sirona’s first acquisition just months after its exit from …

Sirona Medical Acquires Nines Radiology AI Division Read More »

Equip Raises $58M for Virtual, Evidence-Based Eating Disorder Treatment

What You Should Know: Equip, a provider of virtual, evidence-based eating disorder treatment in the U.S., today announced a $58M Series B funding round, bringing the company’s total funding to $75M. The Series B round was led by The Chernin Group (TCG), an early investor in Headspace and was joined by Tiger Global and General …

Equip Raises $58M for Virtual, Evidence-Based Eating Disorder Treatment Read More »

Leveraging A More Impactful Analytics Strategy to Improve Your Health Plan Member CX

Suzanne Cogan, General Manager, SPH Analytics, a Press Ganey Solution Healthcare organizations are increasingly eager to leverage analytics technologies, including machine learning and artificial intelligence (AI), in new ways. One telling sign of this is that the global predictive analytics healthcare market, which was valued at $1.8 billion in 2017, is projected to reach more …

Leveraging A More Impactful Analytics Strategy to Improve Your Health Plan Member CX Read More »

TytoCare Receives CE Mark Approval for its Lung Sounds Analyzer

What You Should Know: – TytoCare has received CE Mark approval for its AI-backed Tyto Lung Sounds Analyzer, a web-based software system designed to aid in the clinical assessment of lung auscultation sound data by analyzing recorded lung sounds to determine whether wheezing is detected within the recording. – The Lung Sounds Analyzer will further enable physicians to better …

TytoCare Receives CE Mark Approval for its Lung Sounds Analyzer Read More »

AI comes of age during Covid-19: Register now and join us for MedCity INVEST in Chicago

The conference takes place March 28-30 at the Ritz Carlton hotel in Chicago. Register now and be part of the conversation, take part in networking opportunities and check out startup pitches across pharma tech, medtech, diagnostics, and digital health.

AI-biotech Terray emerges with $60M and a solution for data problems in drug R&D

Terray Therapeutics uses tiny microarrays to test molecules against targets of interest, then applies artificial intelligence to build large chemical datasets. The startup’s Series A financing will support R&D initially in immunology; the first Terray molecule is expected to reach the clinic in 18 months.

4 Areas Where Technology Can Help Healthcare Workforce Enhancement

Anthony Comfort, SVP of Product Management at VisiQuate Staffing and workforce management have long been one of the most difficult responsibilities borne by healthcare executives, specifically those with responsibility for revenue cycle operations. When the COVID-19 pandemic began, workers in administrative roles (the entire revenue cycle teams) were sent home.  We didn’t know that almost …

4 Areas Where Technology Can Help Healthcare Workforce Enhancement Read More »

Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as early as possible in the drug discovery process. Quris’ BioAI safety prediction platform – which is based on human tissue samples on chips, nanosensors and machine …

Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety Read More »

Ada raises another $30m to push symptom checker in US

Germany’s Ada Health has added another $30 million to its second-round financing first announced last year, saying it will use the new cash to strengthen its presence in the US market. The Berlin-based digital health company – best known for its app to help patients diagnose conditions from symptoms – opened the Series B with …

Ada raises another $30m to push symptom checker in US Read More »

The future of regulatory labeling compliance depends on technology adoption

The life sciences industry is more quickly adapting to new methods, standards and requirements. The focus is now on how to drive greater data governance and quality through a unified framework.  The challenge comes in instituting a framework that will meet regulatory and labeling requirements.

Ada Health pulls in another $30M to expand in the U.S., internationally

Ada Health closed its Series B round after a $30 million extension round. International investors Farallon Capital, Red River West and Bertelsmann Investments provided the additional funds. This follows an initial Series B raise of $90 million last May, which was led by Bayer’s investment arm.

Scopio Secures $50M for AI-Powered Peripheral Blood Smear App

What You Should Know: – Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples. – The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic …

Scopio Secures $50M for AI-Powered Peripheral Blood Smear App Read More »

With 3 inflammation drugs on path to the clinic, Ventus Therapeutics adds $140M

Ventus Therapeutics’ lead programs address pathways associated with inflammation. Led by CEO Marcelo Bigal, the biotech discovers its drugs using computational analysis to understand the structure of proteins and find small molecules that can hit these “undruggable” targets.

Seizing “magic moment” for machine learning, startup Seismic unveils $101M

Machine learning is core to the drug research of Seismic Therapeutic, a new biotech startup developing novel drugs for immunology indications. CEO Jo Viney said the company’s initial focus is addressing dysregulation of adaptive immunity.

AI Marketing for Pharma – The time to rise is Now!

The digitalisation that we all experience daily has affected the way we engage with stakeholders and patients. But how can we make Customer Engagement effective, and how can we leverage technologies like AI and Marketing Automation to their best potential? The key to success lies in implementing a digital health ecosystem, in order to support …

AI Marketing for Pharma – The time to rise is Now! Read More »

Deloitte invests $750M in healthcare, consumer and financial services businesses

The audit, consulting and tax services company is expanding its business ConvergeHEALTH and launching two other businesses in the consumer and financial sectors. It’s investing in everything from new software platforms to hiring software engineers, data scientists and other industry professionals.

C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials

What You Should Know: – Today, Twist Bioscience and cancer genomics startup C2i Genomics announced a partnership to develop whole-genome cancer reference materials. – This resource will provide diagnostic labs around the globe with the ability to better validate and monitor the quality of their whole-genome cancer screening and minimal residual disease (MRD) products for …

C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials Read More »

AI-driven Congruence Therapeutics gets $50M to stabilize misfolded proteins

Biotech startup Congruence Therapeutics is developing novel drugs that treat disease by stabilizing misfolded proteins. Key to the company’s approach is a computational platform that discovers and designs these small molecule stabilizers.

3 Ways Artificial Intelligence Can be Used to Improve Health Equity

John Sargent | Founding Partner, BroadReach Group When I graduated from medical school and took the Hippocratic Oath, I vowed to not just treat the illness on a patient’s medical history form but to treat the person behind the diagnosis. To do this well, clinicians need to understand the whole person and the context in …

3 Ways Artificial Intelligence Can be Used to Improve Health Equity Read More »

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with Finland’s Aalto University to find ways to use the technology to support decentralised trials and streamline the testing process. Now, an extension of the work is starting that will see if AI can be used to reduce …

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups Read More »

Softbank leads Dewpoint’s $150M round as multiple programs march toward clinic

Dewpoint is developing drugs targeting biomolecular condensates, tiny droplets in cells that contain proteins and nucleic acids. Dysfunction of these organelles can play a role in a wide range of diseases, including neurodegenerative disorders and cardiovascular disease.

Glooko’s CEO expects to provide more personalized recommendations to users following German AI acquisition

Digital health company Glooko acquired Germany-based company xbird, a medical AI company with JITAI (Just In Time Adaptive Intervention) technologies to predict patient behavior and offer behavioral changes accordingly to improve outcomes for patients with diabetes. a Medical AI Company

Two announcements involving Walmart show its goal to provide convenience to employees/shoppers

Walmart’s partnership with Health at Home is meant to connect employees and their families with health providers who can best care for them. The retail giant’s collaboration with Quest Diagnostics is aimed at increasing consumer access to high quality lab tests.

Glooko Acquires German Medical AI Company xbird – M&A

What You Should Know: – Glooko, a provider of remote patient monitoring and digital health solutions for diabetes and other chronic conditions, today announced it has acquired xbird, a German-based health AI company developing JITAI ( Just In Time Adaptive Intervention) technologies to support patients and their providers in predicting behavior and managing diabetes. – …

Glooko Acquires German Medical AI Company xbird – M&A Read More »

Could AI help solve the healthcare staffing crisis? One company thinks so

From patient data entry automation to clinical decision support, artificial intelligence can save doctors time while improving quality of care, according to John Frownfelter, CEO of Jvion. He called AI “a key part of the solution” for the nationwide healthcare staffing shortage.

Honeywell Makes Strategic Investment in RapidSOS’s ER Data Platform

What You Should Know: – Today, Honeywell announced it has made a strategic investment in RapidSOS, an NYC-based emergency response data platform, to further modernize and digitize the public safety communications process. – In addition to the strategic investment, Honeywell Connected Life Safety System (CLSS) will integrate with the RapidSOS emergency response data platform to provide faster, more accurate communications with 911 agencies. Terms of the investment were not …

Honeywell Makes Strategic Investment in RapidSOS’s ER Data Platform Read More »

Meet SkinIO, the startup that is bringing virtual specialty care to dermatology

As virtual specialty care options continue to expand and access remains limited to dermatologists, Smart Health Innovation Lab announced this week that the platform, which allows people to do a full-body skin screening using a smartphone app, has joined the healthcare technology accelerator.

Infermedica raises a big round and demos new product

Infermedica is a company that started by creating symptom checking and chatbot functionality in Poland back in 2012. It’s spread to delivering that patient-facing diagnosis functionality via API and now as preparation for a physician visit. Today they announce a $30m series B and demo their new product which helps prepare a visit, and integrates …

Infermedica raises a big round and demos new product Read More »

BenchSci raises $50m to grow AI-powered R&D platform

Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical research internationally. The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving …

BenchSci raises $50m to grow AI-powered R&D platform Read More »

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place. As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around …

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine Read More »

Enhancing Workflow Automation for Healthcare Professionals

Hoala Greevy, Founder & CEO of Paubox Like employers in most industries, healthcare organizations are battling to fill open positions amid the current tight labor market. And new reports show a growing wave of nursing shortages. This widespread scarcity of healthcare workers is forcing providers to cope by having practitioners handle tasks like data entry …

Enhancing Workflow Automation for Healthcare Professionals Read More »

7 Burning Questions from Life Sciences Companies on Using AI Agents

Troy Lase, Associate Director, Commercial Strategic Planning, IQVIA Richard Marcil, Chief Customer Officer, ConversationHEALTH Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching …

7 Burning Questions from Life Sciences Companies on Using AI Agents Read More »

Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform

What You Should Know: – Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings. – The combined company is projected to deliver $350 million in pro forma 2022 …

Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform Read More »

New coalition aims to accelerate responsible AI innovation to transform healthcare

The Artificial Intelligence Industry Innovation Coalition (AI3C) leverages the collective brainpower, experience and expertise of the Brookings Institution, Cleveland Clinic, Duke Health, Intermountain Healthcare, Microsoft, Novant Health, Plug and Play, Providence, UC San Diego and University of Virginia.

BioNTech, InstaDeep showcase early warning system for COVID variants

BioNTech and artificial intelligence startup InstaDeep say they have developed an early warning system that can predict high-risk variants of COVID-19 from their genetic sequences much earlier than with current methods. In testing, the AI was able to correctly identify more than 90% of variants of concern – including the Omicron strain currently spreading around …

BioNTech, InstaDeep showcase early warning system for COVID variants Read More »

Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps

A month after Freenome closed $300 million in financing, Roche has invested another $290 million in the diagnostics developer. The cash infusion comes as Freenome continues a pivotal test in colorectal cancer while it also readies for clinical trials in other types of cancer.

How AI almost led Dr. Farzad Mostashari down the wrong path on health equity

In a virtual panel discussion about public and population health at J.P. Morgan’s annual conference, the CEO of Aledade shared how the quest for efficiency in a world of harried physicians’ practices almost led Aledade to use a flawed ML algorithm to engage at-risk patients of those practices.

We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias?

Ed Ikeguchi, MD, Chief Executive Officer, AiCure Over the last decade, AI has transformed from a futuristic, hype-driven tool, to now being a daily part of our lives. We use AI for everything from unlocking our smartphones, to evaluating our credit scores, to helping clinicians make patient care decisions. In particular, the potential of AI …

We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias? Read More »

Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia

Sanofi’s new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5.2 billion in milestone payments.

Merck backs startup bringing AI to fertility treatment

It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian biotech aims to tackle that problem though the use of artificial intelligence. Toronto-based Future Fertility has developed an AI called Violet that it says can predict the viability …

Merck backs startup bringing AI to fertility treatment Read More »

Amgen pledges $1.9bn to alliance with AI specialist Generate

Fresh from a sizeable funding round that raised $370 million, artificial intelligence-based drug discovery firm Generate Biomedicines has just signed its first major partnering deal with Amgen. The machine learning specialist – founded by venture capital firm Flagship Pioneering in 2018 – is getting $50 million upfront to kick off the alliance, with another £370 …

Amgen pledges $1.9bn to alliance with AI specialist Generate Read More »

Protai Nabs $8M for AI-Powered Drug Discovery Platform

What You Should Know: – Protai, a Tel Aviv, Israel-based AI-powered drug discovery startup, today announced its emergence from stealth, along with an $8 million seed financing round co-led by Grove Ventures and Pitango HealthTech. – Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat …

Protai Nabs $8M for AI-Powered Drug Discovery Platform Read More »

Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs

The biggest biotech IPO of 2021 belongs to a cell therapy developer that has yet to reach the clinic. Cell therapy and artificial intelligence were hot categories of newly public companies, but even though IPOs reached record levels this year that streak is not expected to continue in 2022.

Using Real-World Evidence (RWE) & AI to Enable Better Clinical Care

Dan Riskin, Founder and CEO at Verantos During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option with the patient at hand is limited by the amount and quality of clinical information that is available. While randomized clinical trials are considered the gold standard for establishing the safety …

Using Real-World Evidence (RWE) & AI to Enable Better Clinical Care Read More »

4 ways AI can transform clinical trials

We cannot simply accept that testing new drugs will continue to be a slow and expensive process. AI has the potential to disrupt the current approach to clinical trials — from patient recruitment to adherence monitoring and data collection – and it is time to seize these opportunities.

Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic

Three life science companies unveiled Series B rounds of funding Thursday, early Christmas gifts that top $219 million combined. Along with Verge Genomics, the other companies that raised new capital are Tasso and Brainomix.

Using Machine Learning in the Evolving Landscape of Real-World Data

Zeynep Icten, Ph.D., Director of Data Science Solutions at Panalgo According to the Food and Drug Administration (FDA), the term real-world data (RWD) refers to routinely collected data relating to patient health status and the delivery of healthcare services, and real-world evidence (RWE) is the clinical evidence regarding the usage and potential benefits or risks …

Using Machine Learning in the Evolving Landscape of Real-World Data Read More »

AI specialist Recursion nabs multibillion-dollar Roche partnership

Roche has formed a decade-long alliance with Recursion Pharma that will focus on using machine learning and “industrialised” drug discovery to find new neuroscience and cancer drugs. The Swiss drugmaker is paying $150 million upfront to kick off the strategic-level partnership, which could cover as many as 40 programmes and could be worth “several billion …

AI specialist Recursion nabs multibillion-dollar Roche partnership Read More »

Cancer & immunology biotech Odyssey embarks with $218M, Gary Glick at helm

Odyssey Therapeutics is the latest startup formed by serial biotech entrepreneur Gary Glick. Odyssey’s destination is oncology and immunology drugs that address novel disease targets, and the biotech now has $218 million in Series A financing to fuel the journey.

Harvard spinout Nabla Bio lands $11M to bring AI technology to antibody design

Nabla Bio emerged from the lab of famed Harvard scientists George Church last year, and its antibody discovery technology has already led to five partnerships with pharma and biotech companies. The startup just closed an $11 million seed financing that will support further development of its technology.

AI-based drug discovery firm BenevolentAI cuts SPAC deal

UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt …

AI-based drug discovery firm BenevolentAI cuts SPAC deal Read More »

Nuance Launches Precision Imaging Network for AI-Powered Imaging Insights

What You Should Know: Nuance launches Precision Imaging Network, a new AI-powered cloud-based platform for radiologists. Nuance® Communications, Inc. (NASDAQ: NUAN) launched the Nuance Precision Imaging Network, an AI-powered cloud platform that delivers patient-specific data and insights from diagnostic imaging into existing clinical and administrative workflows across the healthcare ecosystem. Leveraging the scale of Nuance’s PowerScribe and PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network …

Nuance Launches Precision Imaging Network for AI-Powered Imaging Insights Read More »

New private equity investment makes Iodine Software the latest healthcare unicorn

Advent International, a private equity firm, is investing an undisclosed amount into Iodine boosting its valuation beyond $1 billion. The hope is that the company’s AI-powered clinical documentation improvement software can capture a greater share of the market for software products that help hospitals code and bill accurately to receive reimbursement.

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, …

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) Read More »

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. It will take place on June, 20-21, 2022 in Berlin, Germany. One of the major challenges for pharmaceutical executives …

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders Read More »

Second FDA okay for Therapixel’s AI-based mammography tool

France’s Therapixel has secured a second FDA approval for MammoScreen, its artificial intelligence-powered software for detecting cancerous lesions in mammogram images. MammoScreen was approved last year for use alongside conventional digital 2D mammography, and has now been given a green light by the FDA for use with 3D mammograms, also known as digital breast tomosynthesis. …

Second FDA okay for Therapixel’s AI-based mammography tool Read More »

How IVAs is Helping Care Providers and Patients Deal with Delta Variant

Callan Schebella, EVP, Product, Five9 Communicating clearly and effectively with patients is a hallmark of good patient care. However, as the Delta Variant defines the next phase of COVID, many healthcare organizations are experiencing a massive surge in patient communication volume. Not only do they need to communicate important updates about the virus, testing, appointments, …

How IVAs is Helping Care Providers and Patients Deal with Delta Variant Read More »

Cardiologs Awarded FDA Clearance for Pediatric Use of Algorithm

What You Should Know: Cardiologs announced today that the FDA has cleared their algorithm to be used for the pediatric population – younger than 18. Their technology can now analyze ECG readings for atrial arrhythmias across all age groups. Cardiologs, a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud …

Cardiologs Awarded FDA Clearance for Pediatric Use of Algorithm Read More »

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The French drugmaker has been enticed by an artificial intelligence (AI) algorithm developed by Chinese tech giant Baidu, which controls most of China’s search engine traffic and is sometimes referred …

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi Read More »